The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of year-end holidays on delayed cancer diagnoses and survival implications: A population-based study.
 
Abdul Qahar Yasinzai
No Relationships to Disclose
 
Paul Crispen
No Relationships to Disclose
 
Devika Das
Consulting or Advisory Role - Boehringer Ingelheim
 
Stephanie Staras
No Relationships to Disclose
 
Padraic O'Malley
No Relationships to Disclose
 
Ibrahim Nassour
No Relationships to Disclose
 
Kathryn Hitchcock
Research Funding - Merck; Naveris; Novartis
Patents, Royalties, Other Intellectual Property - Provisional patent 63672036 Filing Date: 07-16-2024 A device for delivering total skin electron beam therapy.
Other Relationship - Elekta; Medtronic
(OPTIONAL) Uncompensated Relationships - MVision; Philips Healthcare
 
Ramzi Salloum
No Relationships to Disclose
 
Yi Guo
Consulting or Advisory Role - Merck
 
Thomas George
Consulting or Advisory Role - Arbele; Avammune Therapeutics; BillionToOne; Exact Sciences; KAHR Medical; Nihon Medi-Physics; Summit Therapeutics
Research Funding - Amal Therapeutics (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BillionToOne (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); Elicio Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Ipsen (Inst); Jounce Therapeutics (Inst); Lilly (Inst); Merck (Inst); OncoC4 (Inst); Regeneron (Inst); Seagen (Inst)